Abstract: Apparatuses and methods are provided to predict or diagnose an ischemic event, such as a stroke or a transient ischemic attack (TIA). A machine-learning model such as a neural network is generated that allows for recognition of an ECG consistent with an ischemic event. A system is trained and used to process a recording of ECG data from a patient to generate a prediction indicating a likelihood that the patient will experience a stroke. In other examples, a system is trained and used to process a recording of ECG data from a patient and detect an ischemic event for the patient who did not appear to have such an ischemic event.

Abstract: The present invention provides a method of screening a mammal for the onset or predisposition to the onset of a neuropsychiatric disorder. More particularly, the present invention provides a method of screening a mammal for the onset or predisposition to the onset of schizophrenia by screening for a decrease in the functional level of protein 1 4-3-3?. In a related aspect, the present invention also provides a means of monitoring a patient diagnosed with a neuropsychiatric disorder, such as schizophrenia, by screening for changes to functional levels of protein 14-3-3 ?. This may be useful, for example, in the context of evaluating the effectiveness of a prophylactic or therapeutic treatment regime or otherwise monitoring the impact of physiological or metabolic changes which may occur in a patient.

Abstract: A process for the removal of mercury comprising reacting a sulfide source with HgS solids to increase the size and sedimentation rate of the submicron mercury for removal by filtration or other mechanical processes is described herein. An embodiment of the invention is the use of monothiols to react with mercury to form dissolved mercury, wherein silica with immobilized thiol groups is added to the dissolved mercury, allowing for removal with a coarse filter.

Abstract: A genset including at least one generator for generating electrical energy, which can be driven by a drive device is provided. Also provided is a detection device for detection of the presence of a grid fault in at least one phase of the power grid, a device for determining an operating state of the generator immediately before or upon detection of a grid fault, and a regulating device, to which the signals of the detection device and the device for determining an operating state of the generator can be fed. The regulating device is designed upon detection of a grid fault to reduce the power of the drive device in dependence of that operating state of the generator, which has been determined immediately before or upon detection of the grid fault.

Abstract: The invention relates to an optimized folding display, comprising two facing main side panels (1, 2), a traverse assembly (3) formed by narrow and elongated rectangular boards of semi-flexible sheet material, and fixing means (11, 12, 13, 14) for keeping the traverses fixed to the outer surface of the corresponding side panel (1, 2). The traverses (3) have their planes separated a given distance, so they form an articulated rhombus which can diagonally be closed from an expanded position into a folded position. Furthermore, the display has at least one shelf element (15) located between the two side panels (1, 2) and resting flat on the traverses (3) located at a similar height, forming a shelving assembly.

Abstract: The invention is related to a heat exchanger (1), which comprises: at least one column of parallel tubes (2) which are arranged in a stack and which define a longitudinal direction; a housing (3) inside which the tubes (2) are housed, the tubes (2) being separated from one another, so as to configure a channel for the passage of cooling fluid consisting of: passage sections (4) between tubes (2) that are contiguous in the direction of the stack; passage sections (5) between tubes and housing (3); and baffles (6, 7) that deflect the cooling fluid. According to the invention, the baffles are at least two lamellar bodies (6, 7) of a single piece arranged in a plane perpendicular to the longitudinal direction.

Abstract: Methods of treating or slowing the growth of a lesion associated with geographic atrophy and methods of evaluating a drug or agent for use in treating, reducing the progression of or slowing the growth of a lesion associated with geographic atrophy.

Abstract: The present disclosure provides antibodies and antigen binding fragments thereof that bind to an epitope within an interleukin-3 receptor ?.

Abstract: Methods and apparatus to control a heater associated with a printing nozzle are disclosed. A method comprising controlling a heater associated with a printing nozzle to reduce a heat output of the heater based on a determination that the printing nozzle is outside a print area and printing an image on a substrate using other printing nozzles while the heat output of the heater is reduced.

Abstract: Systems and methods for interacting with a display system using a personal electronic device (PED). The display system may establish communication with and receive user input from the PED. The display system may use the received user input to generate and/or update content displayed on a display of the display system.

Abstract: Deployable display with an expansion system comprising a traction elastic element. The elastic element is basically formed by an elastic band which is annular or is cord-type with engaging elements, and optionally by at least one extension for extending the length of a said band, formed by a plate made of flexible or semi-flexible sheet material provided with engaging elements for said elastic band, the assembly in turn being engaged to side projections of the display. The limiting system is implemented by the reduction in the elastic force and/or by the own resting length of the elastic band in cooperation, where appropriate, with the length of the extension element.

Abstract: A printer is disclosed herein. The printer has a printhead having a plurality of ink nozzles for ejecting ink, a servicing mechanism for capturing the ejected ink from the ink nozzles, to service the printhead, and a control device coupled to the printhead and the servicing mechanism for regulating the servicing. As part of the regulation, the control device continues feeding a substrate towards the printhead during an idle period. The idle period of the printhead can be a duration when printing on the substrate is suspended. Further, the control device regulates ejection of ink from the ink nozzles towards the substrate during the idle period and operates the servicing mechanism during the idle period. In an example, the servicing mechanism captures the ink before the ink reaches the substrate.

Abstract: In a method of starting an internal combustion engine having a plurality of piston-cylinder units wherein there are dead volumes upstream of the piston-cylinder units, wherein upon an attempt at starting the internal combustion engine, the pistons are driven in the cylinders by an auxiliary motor. The maximum permissible duration of a starting attempt is restricted by a predetermined starting time (ts) of the internal combustion engine. The starting time (ts) is calculated and predetermined prior to or at the beginning of a starting attempt of the internal combustion engine depending on a state of the internal combustion engine and/or the auxiliary motor.

Abstract: The present invention provides a method of screening a mammal for the onset or predisposition to the onset of a neuropsychiatric disorder. More particularly, the present invention provides a method of screening a mammal for the onset or predisposition to the onset of schizophrenia by screening for a decrease in the functional level of protein 14-3-3?. In a related aspect, the present invention also provides a means of monitoring a patient diagnosed with a neuropsychiatric disorder, such as schizophrenia, by screening for changes to functional levels of protein 14-3-3?. This may be useful, for example, in the context of evaluating the effectiveness of a prophylactic or therapeutic treatment regime or otherwise monitoring the impact of physiological or metabolic changes which may occur in a patient.

Abstract: Systems and methods for interacting with a display system using a personal electronic device (PED). The display system may establish communication with and receive user input from the PED. The display system may use the received user input to generate and/or update content displayed on a display of the display system.

Abstract: An internal combustion engine including a pre-chamber connected to a pre-chamber feed conduit for supplying the pre-chamber with a fuel (F), and a main combustion chamber. Fuel (F) in the main combustion chamber can be ignited by an ignition flare which passes from the at least one pre-chamber into the at least one main combustion chamber and which is produced by ignition of fuel (F) in the pre-chamber. At least one valve can be open-loop or closed-loop controlled by an open-loop or closed-loop control device depending on a parameter characteristic of a change in a power produced by the internal combustion engine, and/or by which a pre-chamber fuel flow directed through the pre-chamber feed conduit to the at least one pre-chamber can be at least partially diverted into a volume separate from the at least one pre-chamber.

Abstract: The invention provides a method for the treatment of Ph+ leukemia in a patient comprising administering to the patient (i) a BCR-ABL tyrosine kinase inhibitor, and (ii) an agent which selectively binds to a cell surface receptor expressed on Ph+ leukemic stem cells. The invention further provides for the use of (i) and (ii) in, or in the manufacture of a medicament for, the treatment of Ph+ leukemia in a patient; and a composition for the treatment of Ph+ leukemia in a patient comprising (i) and (ii); and kits comprising (i) and (ii). In some embodiments, the tyrosine kinase inhibitor is or is not imatinib; or is selected from the group consisting of dasatinib, nilotinib, bosutinib, axitinib, cediranib, crizotinib, damnacanthal, gefitinib, lapatinib, lestaurtinib, neratinib, semaxanib, sunitinib, toceranib, tyrphostins, vandetanib, vatalanib, INNO-406, AP24534, XL228, PHA-739358, MK-0457, SGX393 and DC2036; or is selected from the group consisting of dasatinib and nilotinib.

Abstract: Systems and methods for a head tracked stereoscopic display system that uses light field type data may include receiving light field type data corresponding to a scene. The stereoscopic display system may track a user's head. Using the received light field type data and the head tracking, the system may generate three dimensional (3D) virtual content that corresponds to a virtual representation of the scene. The stereoscopic display system may then present the 3D virtual content to a user. The stereoscopic display system may present a left eye perspective image and a right eye perspective image of the scene to the user based on the position and orientation of the user's head. The images presented to the user may be updated based on a change in the position or the orientation of the user's head or based on receiving user input.

Abstract: The present invention relates to a CFI bioactivity assay designed to quantitatively measure (a) CFI bioactivity of plasma or other body fluids; and (b) bioactivity of CFI in plasma or other body fluids of a human patient afflicted by a disease that involves amyloid deposition in tissues, in particular Alzheimer disease, AMD, glaucoma, or beta-amyloid cataract formation.

Abstract: A method of making a replacement heart valve device whereby a fragment of biocompatible tissue material is treated and soaked in one or more alcohol solutions and a solution of glutaraldehyde. The dried biocompatible tissue material is folded and rehydrated in such a way that forms a two- or three-leaflet/cusp valve without affixing of separate cusps or leaflets or cutting slits into the biocompatible tissue material to form the cusps or leaflets. After the biocompatible tissue material is folded, it is affixed at one or more points on the outer surface to the inner cavity or a stent.